Sciencast Management LP Sells 32,903 Shares of DENTSPLY SIRONA Inc. $XRAY

Key Points

• Sciencast Management LP reduced its holdings in DENTSPLY SIRONA by 47.5%, now owning 36,373 shares worth $543,000 after selling 32,903 shares in Q1.
• DENTSPLY SIRONA reported $0.52 earnings per share for the latest quarter, exceeding analysts' expectations, but its revenue decreased by 4.9% compared to the previous year.
• The company declared a quarterly dividend of $0.16, which represents a 4.5% yield and is set to be paid on October 10th.

Sciencast Management LP lessened its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 47.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 36,373 shares of the medical instruments supplier's stock after selling 32,903 shares during the quarter. Sciencast Management LP's holdings in DENTSPLY SIRONA were worth $543,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the business. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of DENTSPLY SIRONA during the 1st quarter valued at $25,000. Brooklyn Investment Group bought a new position in shares of DENTSPLY SIRONA in the 1st quarter worth about $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of DENTSPLY SIRONA in the 1st quarter worth about $26,000. Caitong International Asset Management Co. Ltd raised its position in shares of DENTSPLY SIRONA by 8,003.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier's stock worth $34,000 after acquiring an additional 2,241 shares in the last quarter. Finally, Allworth Financial LP increased its position in DENTSPLY SIRONA by 175.8% in the 1st quarter. Allworth Financial LP now owns 3,949 shares of the medical instruments supplier's stock valued at $54,000 after buying an additional 2,517 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Barrington Research cut their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating for the company in a research note on Friday, August 8th. UBS Group cut their target price on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Stifel Nicolaus dropped their price objective on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating on the stock in a research note on Friday, August 8th. Finally, Wall Street Zen downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Two investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and an average target price of $18.64.

DENTSPLY SIRONA Stock Performance

XRAY stock traded down $0.41 during midday trading on Friday, reaching $13.53. 3,721,038 shares of the company's stock traded hands, compared to its average volume of 2,573,833. The company has a 50-day moving average price of $14.73 and a two-hundred day moving average price of $15.00. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $27.48. The firm has a market capitalization of $2.70 billion, a PE ratio of -2.85, a price-to-earnings-growth ratio of 0.85 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.02. The firm had revenue of $936.00 million for the quarter, compared to analysts' expectations of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business's quarterly revenue was down 4.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.49 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $0.64 annualized dividend and a dividend yield of 4.7%. DENTSPLY SIRONA's dividend payout ratio is presently -13.50%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.